BatesCarey’s Adam H. Fleischer and David J. Buishas examine: 1) what litigation has already arisen involving the coronavirus; 2) what insurance endorsements are likely to be implicated; 3) how states may seek to regulate such coverage, and; 4) what science claims handlers may need to study. Click here.